Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Ruperto, N., Brunner, H. I., Synoverska, O., Ting, T. V., Mendoza, C. A., Spindler, A., Vyzhga, Y., Marzan, K., Grebenkina, L., Tirosh, I., Imundo, L., Jerath, R., Kingsbury, D. J., Sozeri, B., Vora, S. S., Prahalad, S., Zholobova, E., Butbul Aviel, Y., Chasnyk, V., … Weiss, J. (2021). Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. The Lancet, 398(10315), 1984–1996. https://doi.org/10.1016/s0140-6736(21)01255-1
Authors:
Nicolino Ruperto
Hermine I Brunner
Olga Synoverska
Tracy V Ting
Carlos Abud Mendoza
Alberto Spindler
Yulia Vyzhga
Katherine Marzan
Lyudmila Grebenkina
Irit Tirosh
Lisa Imundo
Rita Jerath
Daniel J Kingsbury
Betul Sozeri
Sheetal S Vora
Sampath Prahalad
Elena Zholobova
Yonatan Butbul Aviel
Vyacheslav Chasnyk
Melissa Lerman
Kabita Nanda
Heinrike Schmeling
Heather Tory
Yosef Uziel
Diego O Viola
Holly B Posner
Keith S Kanik
Ann Wouters
Cheng Chang
Richard Zhang
Irina Lazariciu
Ming-Ann Hsu
Ricardo M Suehiro
Alberto Martini
Daniel J Lovell
Affiliated Authors:
Lisa Imundo
Subjects:
Arthritis, Juvenile (MeSH)
Janus Kinase Inhibitors (MeSH)
Piperidines (MeSH)
Pyrimidines (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/s0140-6736(21)01255-1
PMID:
34767764
DOI:
10.1016/s0140-6736(21)01255-1
Journal:
Lancet
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: